{"database": "lobbying", "table": "lobbying_activities", "rows": [[2020101, "9c8a346f-6978-4fdd-885c-a69de13adc3a", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "GLOBAL HEALTHY LIVING FOUNDATION", 2017, "third_quarter", "HCR", "Real World Evidence\nPatient Reported Outcomes\nHatch Waxman Amendments to the Food and Drug Cosmetic Act\nMedical Product Communications Act of 2017, HR 1703\nPrescription Drug Price Transparency Act, HR 1316", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2017-10-05T16:24:34.897000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2020101"], "units": {}, "query_ms": 0.4497280460782349, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}